From USFDA
SMS Pharmaceuticals has received Establishment Inspection Report from USFDA for its manufacturing facility - Unit II located at Bachupally, Hyderabad, Telangana. The facility was inspected in November 2017 and there were no Form 483 observations during the inspection.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
